Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity

Abstract

Cisplatin is a platinum-based chemotherapeutic that has long since been effective against a variety of solid-cancers, substantially improving the five-year survival rates for cancer patients. Its use has also historically been limited by its adverse drug reactions, or cisplatin-induced toxicities (CITs). Of these reactions, cisplatin-induced nephrotoxicity (CIN), cisplatin-induced peripheral neuropathy (CIPN), and cisplatin-induced ototoxicity (CIO) are the three most common of several CITs recognised thus far. While the anti-cancer activity of cisplatin is well understood, the mechanisms driving its toxicities have only begun to be defined. Most of the literature pertains to damage caused by oxidative stress that occurs downstream of cisplatin treatment, but recent evidence suggests that the instigator of CIT development is inflammation. Cisplatin has been shown to induce pro-inflammatory signalling in CIN, CIPN, and CIO, all of which are associated with persisting markers of inflammation, particularly from the innate immune system. This review covered the hallmarks of inflammation common and distinct between different CITs, the role of innate immune components in development of CITs, as well as current treatments targeting pro-inflammatory signalling pathways to conserve the use of cisplatin in chemotherapy and improve long-term health outcomes of cancer patients.

Red Blood Cell Membrane-Camouflaged Gold Nanoparticles for Treatment of Melanoma

“…However, due to the resistance of patients to CP, conventional therapy has a disappointing effect [6]. Besides, CP also has systemic toxicity, including central nervous system damage and nephrotoxicity [7]. All of these factors limit its application in the treatment of melanoma.…”

Sustainable Release of Propranolol Hydrochloride Laden with Biconjugated-Ufasomes Chitosan Hydrogel Attenuates Cisplatin-Induced Sciatic Nerve Damage in In Vitro/In Vivo Evaluation

“…Additionally, cisplatin induced neurotoxicity with a severe inflammatory and proinflammatory mediator’s induction, such as TNF α and NF-κB [ 201 , 202 ]. TNF-α is an essential mediator of chronic inflammation and a significant contributor to peripheral nerve injury and neuropathic pain [ 203 , 204 ].…”

Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer

“…Inflammation is also reported to be involved in developing the side effects of chemotherapy [ 58 ]. Chemotherapy-induced toxicity of cisplatin has been reported to be enhanced by inflammation [ 59 , 60 ]. Therefore, the presence of inflammation before chemotherapy may influence chemotherapy discontinuation due to the side effects of the anticancer drugs.…”